Multiple Myeloma Coverage From Every Angle
Editors:
Shaji K. Kumar, MD
Prashant Kapoor, MD, FACP
Advertisement
Advertisement

Videos

Charles von Gunten, MD, PhD, on Protecting Opioid Access: NCCN Guideline Recommendations

Shaji K. Kumar, MD, on Newly Diagnosed Multiple Myeloma: Evolving Treatment Approaches

Simron Singh, MD, MPH, on Patient-Centered Care: Measuring Experience

Sandra E. Kurtin, PhDc, ANP-C, AOCN, on Adhering to Ixazomib

Natalie S. Callander, MD, on Using Carfilzomib in Multiple Myeloma

Shaji K. Kumar, MD, on Multiple Myeloma Treatment: Expert Perspective

Sagar Lonial, MD, on Multiple Myeloma: Upfront, Relapsed, and Transplant Options

Sarah A. Holstein, MD, PhD, on Multiple Myeloma: New Induction Therapies

Sagar Lonial, MD, on Multiple Myeloma: Managing a Challenging Case

Paul G. Richardson, MD, on Multiple Myeloma: Results From the OPTIMISMM Trial

Patrick J. Kiel, PharmD, BCPS, BCOP, on Treating Multiple Myeloma

Sandra E. Kurtin, PhDc, ANP-C, AOCN, on Multiple Myeloma: An Advanced Practitioner’s Perspective

A Patient’s Story: NCCN Guidelines for Patients® Helped Me Ask The Right Questions

A Patient's Story: How NCCN Guidelines for Patients® Helped Me and My Caregiver

Crystal S. Denlinger, MD, and Ann H. Partridge, MD, MPH, on Making Sense of Guidelines and Guidance

R. Donald Harvey, PharmD, BCOP, FCCP, FHOPA, on Administering Daratumumab

Muzaffar H. Qazilbash, MD, on Multiple Myeloma: Results From a Treatment Trial

David Siegel, MD, PhD, on Relapsed / Refractory Multiple Myeloma: Final Results From the ASPIRE Trial

Adam D. Cohen, MD, on Multiple Myeloma: Findings on CART-BCMA Infusions

Mollie Reed, MSN, RN, ACNP-BC, on Managing Rash Linked to TKIs

Hans C. Lee, MD, on Administering Daratumumab

Kathleen Colson, RN, BSN, BS, on Multiple Myeloma: Managing Treatment-Related Complications

Thomas W. LeBlanc, MD, on Hematologic Malignancies: The Case for Palliative Care

Shaji K. Kumar, MD, on NCCN Multiple Myeloma Guidelines: Process, Evolution, and Clinical Practice

Areej El-Jawahri, MD, on Stem Cell Transplant Survivors: Improving Sexual Function and Quality of Life

Kathleen Colson, RN, BSN, BS, on Preventing Infusion Reactions to Daratumumab

Shaji K. Kumar, MD, on Multiple Myeloma: Management in Those Eligible for Transplant

Natalie S. Callander, MD, on Newly Diagnosed Multiple Myeloma: What Early-Phase Trials Suggest

Noopur S. Raje, MD, and Kenneth C. Anderson, MD, on Myeloma Bone Disease: Denosumab and Zoledronic Acid

Natalie S. Callander, MD, on Multiple Myeloma: Cost Effectiveness of Drugs Used to Treat Relapsed/Refractory Disease

Noopur S. Raje, MD, and Kenneth C. Anderson, MD, on Myeloma Bone: Updated Results on Anti-BCMA CAR T-Cell Therapy

Natalie S. Callander, MD, on Relapsed/Refractory Multiple Myeloma: Expert Perspective on New Research

Kenneth C. Anderson, MD, and Francesca M. Gay, MD, on Newly Diagnosed Multiple Myeloma: Results From the FORTE Trial

The JNCCN Spotlight

Welcome to JNCCN 360

Copyright © 2018 National Comprehensive Cancer Network, All Rights Reserved
By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.